PABVX
Price
$16.19
Change
-$0.05 (-0.31%)
Updated
Aug 28 closing price
Net Assets
2.35B
VMVAX
Price
$89.47
Change
-$0.27 (-0.30%)
Updated
Aug 28 closing price
Net Assets
31.04B
Interact to see
Advertisement

PABVX vs VMVAX

Header iconPABVX vs VMVAX Comparison
Open Charts PABVX vs VMVAXBanner chart's image
Principal MidCap Value I R5
Price$16.19
Change-$0.05 (-0.31%)
VolumeN/A
Net Assets2.35B
Vanguard Mid-Cap Value Index Admiral
Price$89.47
Change-$0.27 (-0.30%)
VolumeN/A
Net Assets31.04B
PABVX vs VMVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PABVX vs. VMVAX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABVX is a Buy and VMVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 31B vs. PABVX (2.35B). VMVAX pays higher dividends than PABVX: VMVAX (2.22) vs PABVX (1.22). PABVX was incepted earlier than VMVAX: PABVX (21 years) vs VMVAX (14 years). PABVX (0.90) is less costly to investors than VMVAX (0.07). PABVX is a more actively managed with annual turnover of: 55.30 vs. VMVAX (19.00). PABVX has a lower initial minimum investment than VMVAX: PABVX (0) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 6.80 vs. PABVX (-9.51). VMVAX return over 5 years is better than : 67.15 vs. PABVX (30.56).
PABVXVMVAXPABVX / VMVAX
Total Expense Ratio0.880.071,257%
Annual Report Gross Expense Ratio0.900.071,286%
Fund Existence21 years14 years-
Gain YTD5.5927.18078%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.35B31B8%
Annual Yield % from dividends1.222.2255%
Returns for 1 year-9.516.80-140%
Returns for 3 years2.4526.179%
Returns for 5 years30.5667.1546%
Returns for 10 years27.23102.2427%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIESX18.94N/A
N/A
JPMorgan Developed International Value I
GEGTX84.37N/A
N/A
Columbia Large Cap Growth Inst
YFSIX17.11N/A
N/A
AMG Yacktman Global I
OFIGX12.54N/A
N/A
Oberweis Focused International Gr Fd
FCUCX20.21N/A
N/A
NYLI PineStone U.S. Equity Class C